1. Department of Pathology, University of Otago, and
2. Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand;
3. Kenya Medical Research Institute–Wellcome Trust Research Programme, Kilifi;
4. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom;
5. Microbiology Laboratory, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand;
6. Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and
7. Emmes Corporation, Rockville, Maryland;
8. Global Disease Detection Center, Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi;
9. Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia;
10. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
11. International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab;
12. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
13. Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore;
14. Bill & Melinda Gates Foundation, Seattle, Washington;
15. Medical Research Council, Respiratory and Meningeal Pathogens Research Unit and
16. Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa;
17. Center for Global Health and Development, Boston University School of Public Health, Massachusetts;
18. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
19. Medical Research Council Unit, Basse, The Gambia;
20. Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
21. Department of Biomedical Sciences, School of Health Sciences, University of Zambia, and
22. Zambia Center for Applied Health Research and Development, Lusaka;
23. Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa;
24. Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia;
25. Department of Medicine, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore;
26. Milken Institute School of Public Health, Department of Epidemiology and Biostatistics, George Washington University, District of Columbia;
27. Medical Microbiology Department, Lagos University Teaching Hospital, Nigeria;
28. Centre pour le Développement des Vaccins (CVD-Mali), Bamako;
29. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
30. Department of Paediatrics, University of Auckland, and
31. Centre for International Health, University of Otago, Dunedin, New Zealand